WallStreetZenWallStreetZen

NASDAQ: CARA
Cara Therapeutics Inc Stock Ownership - Who owns Cara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cara Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Christopher PosnerPRESIDENT AND CEO2024-08-014,149$0.35
$1.45kSell
Christopher PosnerPRESIDENT AND CEO2024-05-023,936$0.75
$2.95kSell
Joana GoncalvesCHIEF MEDICAL OFFICER2024-04-052,753$0.83
$2.28kSell
Scott TerrillionSECY CHIEF COMPLIANCE G.C.2024-04-052,753$0.83
$2.28kSell
Christopher PosnerPRESIDENT AND CEO2024-02-295,834$0.89
$5.19kSell
Joana GoncalvesCHIEF MEDICAL OFFICER2024-02-293,293$0.89
$2.93kSell
Scott TerrillionSECY CHIEF COMPLIANCE G.C.2024-02-293,293$0.89
$2.93kSell
Christopher PosnerPRESIDENT AND CEO2024-02-0835,575$0.53
$18.85kSell
Christopher PosnerPRESIDENT AND CEO2024-02-014,981$0.55
$2.74kSell
Christopher PosnerPresident and CEO2023-11-023,796$1.22
$4.63kSell

1 of 1

CARA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CARA insiders and whales buy or sell their stock.

CARA Shareholders

What type of owners hold Cara Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Csl Ltd13.49%7,396,770$2.15MInsider
Vifor International Ltd13.49%7,396,770$2.15MInsider
Dean Slagel7.16%3,925,825$1.14MInsider
Rho Ventures Vi LP6.51%3,568,057$1.03MInsider
Martin Vogelbaum6.34%3,479,064$1.01MInsider
Vanguard Group Inc4.10%2,250,334$652.60kInstitution
Disciplined Growth Investors Inc3.53%1,935,718$561.36kInstitution
Chescapmanager LLC3.10%1,702,110$493.61kInstitution
Charles Phd Moller2.87%1,576,404$457.16kInsider
Farallon Capital Management LLC2.84%1,556,251$451.31kInstitution

1 of 3

CARA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CARA32.26%54.87%Net SellingNet Selling
EVGN77.05%0.00%
LYRA50.03%13.22%Net Buying
MTNB56.56%43.44%
IPA6.07%0.00%
View Top Biotech Stocks

Cara Therapeutics Stock Ownership FAQ

Who owns Cara Therapeutics?

Cara Therapeutics (NASDAQ: CARA) is owned by 32.26% institutional shareholders, 54.87% Cara Therapeutics insiders, and 12.88% retail investors. Csl Ltd is the largest individual Cara Therapeutics shareholder, owning 7.40M shares representing 13.49% of the company. Csl Ltd's Cara Therapeutics shares are currently valued at $2.04M.

If you're new to stock investing, here's how to buy Cara Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.